Integral Health Asset Management, LLC — 13F Holdings & Portfolio
CIK 1773206 · latest 13F-HR filed 2026-08-14
Integral Health Asset Management, LLC manages $2.53B in 13F-reported U.S. long-equity assets across 92 reported positions as of its 2026-06-30 13F-HR filing. Its largest disclosed positions are RVMD (11.10%), INSM (6.74%), CYTK (5.38%). Quarter over quarter (versus its 2026-03-31 filing) the fund opened 29 new positions and exited 26; 39 existing positions rose in reported value and 16 fell.
AUM is the long-equity portion reported on Form 13F-HR. Excludes short positions, cash, foreign holdings, and non-13F assets. For informational purposes only — not investment advice.
Long-equity book
Distinct positions
Filed 2026-08-14
vs 2026-03-31
Portfolio charts
Latest quarter's book, what changed, and how the portfolio has evolved across filings.
| Name | Title / Status | Ownership | Type |
|---|
Quarter-over-quarter changes
Changes in reported position value vs the prior 13F, so price moves count too, not just shares bought or sold.
Top Adds (vs prior quarter)
- REVOLUTION MEDICINES INC$135.0M +92.6%
- CVS HEALTH CORP$103.0M +956.3%
- AXSOME THERAPEUTICS INC.$67.5M +1141.3%
- EDWARDS LIFESCIENCES CORP$42.9M +315.3%
- EDGEWISE THERAPEUTICS INC$30.9M +61.2%
Top Trims
- INSMED INC-$74.7M -30.5%
- REGENERON PHARMACEUTICALS-$40.7M -62.0%
- BRIGHTSPRING HEALTH SVCS INC-$14.9M -28.0%
- MINERALYS THERAPEUTICS INC-$8.2M -40.2%
- NOVARTIS AG-$6.8M -17.9%
New Positions
- ABBOTT LABORATORIES$36.3M
- UNITEDHEALTH GROUP INC$35.3M
- TENET HEALTHCARE CORP$30.9M
- SPYRE THERAPEUTICS INC$28.9M
- NOVO-NORDISK A S$28.8M
Exited Positions
- ASTRAZENECA PLC$49.3M
- ASCENDIS PHARMA A/S$26.3M
- FRESENIUS MEDICAL CARE AG$17.5M
- INTUITIVE SURGICAL INC$16.1M
- TARSUS PHARMACEUTICALS INC$14.0M
Integral Health Asset Management, LLC Holdings (2026-06-30)
Rows tagged Call or Put are options positions, not stock. Per SEC Form 13F-HR, Value shows the notional value of the underlying (shares covered × underlying price), not the option premium. Shares is the number of underlying shares covered (divide by 100 for contract count).
| # | Issuer | Symbol | CUSIP | Value | Weight | Shares | Type |
|---|---|---|---|---|---|---|---|
| 1 | REVOLUTION MEDICINES INC | RVMD | 76155X100 | $280.9M | 11.10% | 1,500,000 | SH |
| 2 | INSMED INC | INSM | 457669307 | $170.6M | 6.74% | 1,600,000 | SH |
| 3 | CYTOKINETICS INC | CYTK | 23282W605 | $136.3M | 5.38% | 1,600,000 | SH |
| 4 | CVS HEALTH CORP | CVS | 126650100 | $113.8M | 4.49% | 1,100,000 | SH |
| 5 | EDGEWISE THERAPEUTICS INC | EWTX | 28036F105 | $81.3M | 3.21% | 2,000,000 | SH |
| 6 | VERA THERAPEUTICS INC | VERA | 92337R101 | $75.1M | 2.97% | 1,750,000 | SH |
| 7 | AXSOME THERAPEUTICS INC. | AXSM | 05464T104 | $73.4M | 2.90% | 300,000 | SH |
| 8 | CARDINAL HEALTH INC | CAH | 14149Y108 | $71.3M | 2.81% | 300,000 | SH |
| 9 | ROIVANT SCIENCES LTD | ROIV | G76279101 | $70.8M | 2.80% | 2,000,000 | SH |
| 10 | RHYTHM PHARMACEUTICALS INC | RYTM | 76243J105 | $61.1M | 2.41% | 550,000 | SH |
| 11 | EDWARDS LIFESCIENCES CORP | EW | 28176E108 | $56.5M | 2.23% | 625,000 | SH |
| 12 | REVOLUTION MEDICINES INC Put | RVMD | 76155X100 | $56.2M | 2.22% | 300,000 | SH |
| 13 | ALIGNMENT HEALTHCARE INC | ALHC | 01625V104 | $47.6M | 1.88% | 2,000,000 | SH |
| 14 | MERCK & CO INC | MRK | 58933Y105 | $45.0M | 1.78% | 350,000 | SH |
| 15 | QUEST DIAGNOSTICS INC | DGX | 74834L100 | $42.4M | 1.67% | 200,000 | SH |
| 16 | UNIQURE NV | QURE | N90064101 | $41.5M | 1.64% | 900,000 | SH |
| 17 | SCHOLAR ROCK HLDG CORP | SRRK | 80706P103 | $41.2M | 1.63% | 750,000 | SH |
| 18 | BOSTON SCIENTIFIC CORP | BSX | 101137107 | $38.4M | 1.52% | 900,000 | SH |
| 19 | BRIGHTSPRING HEALTH SVCS INC | BTSG | 10950A106 | $38.4M | 1.52% | 550,000 | SH |
| 20 | ABBOTT LABORATORIES | ABT | 002824100 | $36.3M | 1.43% | 400,000 | SH |
| 21 | UNITEDHEALTH GROUP INC | UNH | 91324P102 | $35.3M | 1.40% | 85,000 | SH |
| 22 | LIFESTANCE HEALTH GROUP INC | LFST | 53228F101 | $32.1M | 1.27% | 3,000,000 | SH |
| 23 | NOVARTIS AG | NVS | 66987V109 | $31.3M | 1.24% | 200,000 | SH |
| 24 | TANGO THERAPEUTICS INC | TNGX | 87583X109 | $31.3M | 1.23% | 1,000,000 | SH |
| 25 | TENET HEALTHCARE CORP | THC | 88033G407 | $30.9M | 1.22% | 165,000 | SH |
| 26 | SPYRE THERAPEUTICS INC | SYRE | 00773J202 | $28.9M | 1.14% | 325,000 | SH |
| 27 | NOVO-NORDISK A S | NVO | 670100205 | $28.8M | 1.14% | 600,000 | SH |
| 28 | DEFINIUM THERAPEUTICS INC | DFTX | 24477V105 | $25.9M | 1.02% | 550,000 | SH |
| 29 | NEUROCRINE BIOSCIENCES INC | NBIX | 64125C109 | $25.3M | 1.00% | 150,000 | SH |
| 30 | REGENERON PHARMACEUTICALS | REGN | 75886F107 | $24.9M | 0.99% | 40,000 | SH |
| 31 | IONIS PHARMACEUTICALS INC Call | IONS | 462222100 | $23.8M | 0.94% | 300,000 | SH |
| 32 | BIOGEN INC | BIIB | 09062X103 | $21.6M | 0.85% | 100,000 | SH |
| 33 | TRAVERE THERAPEUTICS INC | TVTX | 89422G107 | $21.3M | 0.84% | 375,000 | SH |
| 34 | LANTHEUS HLDGS INC | LNTH | 516544103 | $21.1M | 0.83% | 190,000 | SH |
| 35 | GLAUKOS CORP | GKOS | 377322102 | $21.0M | 0.83% | 150,000 | SH |
| 36 | ORIC PHARMACEUTICALS INC | ORIC | 68622P109 | $20.6M | 0.81% | 1,900,000 | SH |
| 37 | BRIDGEBIO PHARMA INC | BBIO | 10806X102 | $20.5M | 0.81% | 275,000 | SH |
| 38 | VERTEX PHARMACEUTICALS INC | VRTX | 92532F100 | $19.9M | 0.78% | 40,000 | SH |
| 39 | ALUMIS INC | ALMS | 022307102 | $19.7M | 0.78% | 700,000 | SH |
| 40 | ELEVANCE HEALTH INC FORMERLY | ELV | 036752103 | $19.3M | 0.76% | 50,000 | SH |
| 41 | CENTENE CORP DEL | CNC | 15135B101 | $19.3M | 0.76% | 300,000 | SH |
| 42 | ERASCA INC | ERAS | 29479A108 | $18.3M | 0.72% | 1,000,000 | SH |
| 43 | ELI LILLY & CO | LLY | 532457108 | $18.0M | 0.71% | 15,000 | SH |
| 44 | ARROWHEAD PHARMACEUTICALS IN | ARWR | 04280A100 | $16.3M | 0.64% | 200,000 | SH |
| 45 | ENVISTA HOLDINGS CORPORATION | NVST | 29415F104 | $15.8M | 0.62% | 600,000 | SH |
| 46 | MEDTRONIC PLC | MDT | G5960L103 | $15.6M | 0.62% | 200,000 | SH |
| 47 | WATERS CORP | WAT | 941848103 | $15.0M | 0.59% | 40,000 | SH |
| 48 | LIVANOVA PLC | LIVN | G5509L101 | $14.8M | 0.58% | 180,000 | SH |
| 49 | NOVO-NORDISK A S Call | NVO | 670100205 | $14.4M | 0.57% | 300,000 | SH |
| 50 | FORTE BIOSCIENCES INC | FBRX | 34962G208 | $14.3M | 0.57% | 675,000 | SH |
| Period | Filed | AUM | Holdings | Accession |
|---|---|---|---|---|
| 2026-06-30 | 2026-08-14 | $2.53B | 92 | 0001172661-26-003449 |
| 2026-03-31 | 2026-05-15 | $2.09B | 90 | 0001172661-26-002081 |
| 2025-12-31 | 2026-02-17 | $2.01B | 86 | 0001172661-26-000915 |
| 2025-09-30 | 2025-11-14 | $1.48B | 76 | 0001172661-25-004839 |
19TH FLOOR
NEW YORK, NY 10022